Progesterone in the clinical treatment of acute traumatic brain injury

Expert Opinion on Investigational Drugs

Volumn 19, Issue 7, 2010, Pages 847-857

  Stein, Donald G ^a   Wright, David W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neuroprotection; Neurosteroid; Progesterone; Traumatic brain injury

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CITICOLINE; CONJUGATED ESTROGEN; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; HUMAN GROWTH HORMONE; MAGNESIUM SULFATE; METHYLPHENIDATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; PROGESTERONE; SODIUM CHLORIDE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; HORMONE ACTION; HUMAN; INDUCED HYPOTHERMIA; NEUROPROTECTION; NONHUMAN; REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ANIMALS; BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; HUMANS; NEUROPROTECTIVE AGENTS; PROGESTERONE; TREATMENT OUTCOME;

EID: 77953446657     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.2010.489549     Document Type: Review

References (112)

1. Schouten JW. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr Opin Crit Care 2007;13(2):134-142
2. Roberts I, Schierhout G, Alderson P. Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review. J Neurol Neurosurg Psychiatry 1998;65(5):729-733
3. Bullock R, Chesnut RM, Clifton G, et al. Guidelines for the management of severe head injury. Brain Trauma Foundation. Eur J Emerg Med 1996;3(2):109-127
4. Fan L, Young PR, Barone FC, et al. Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res 1996;36(2):287-291
5. Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev 2005;(1):CD000196
6. Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 2010;7(1):115-126
7. Ippolito CJ. Battlefield TBI: blast and aftermath. Psychiatric Times 2007. Available from: www. psychiatrictimes.com/display/article/10168/56916. [Accessed October 2009]
8. Gomes JA, Stevens RD, Lewin JJ III, et al. Glucocorticoid therapy in neurologic critical care. Crit Care Med 2005;33(6):1214-1224
9. Vink R, Van Den Heuvel C. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opin Investig Drugs 2004;13(10):1263-1274
10. Watson NF, Barber JK, Doherty MJ, et al. Does glucocorticoid administration prevent late seizures after head injury? Epilepsia 2004;45(6):690-694
11. Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004;364(9442):1321-1328
12. Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005;365(9475):1957-1959
13. Temkin NR, Anderson GD, Winn HR, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 2007;6(1):29-38
14. Xiong Y, Mahmood A, Chopp M. Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs 2009;14(1):67-84
15. Vink R, Nimmo AJ. Multifunctional drugs for head injury. Neurotherapeutics 2009;6(1):28-42
16. Hatton J, Rosbolt B, Empey P, et al. Dosing and safety of cyclosporine in patients with severe brain injury. J Neurosurg 2008;109(4):699-707
17. Clinical Trials.gov. Available from: http://clinicaltrials.gov/ct2/show/ NCT00260052?term=TRAUMATIC+ BRAIN+INJURY+erythropoietin&rank=2. [Accessed 22 February 2010]
18. Grasso G, Graziano F, Sfacteria A, et al. Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage. Neurosurgery 2009;65(4):763-9; discussion 9-70
19. Mammis A, McIntosh TK, Maniker AH. Erythropoietin as a neuroprotective agent in traumatic brain injury review. Surg Neurol 2009;71(5):527-31; discussion 531
20. Poole NA, Agrawal N. Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review. Brain Inj 2008;22(7-8):519-534
21. Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 2001;57(9):1595-1602
22. Adelson PD, Bratton SL, Carney NA, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 1. Introduction. Pediatr Crit Care Med 2003;4(Suppl 3):S2-4
23. Bayir H, Adelson PD, Wisniewski SR, et al. Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. Crit Care Med 2009;37(2):689-695
24. Harris OA, Muh CR, Surles MC, et al. Discrete cerebral hypothermia in the management of traumatic brain injury: a randomized controlled trial. J Neurosurg 2009;110(6):1256-1264
25. Hutchison JS, Ward RE, Lacroix J, et al. Hypothermia therapy after traumatic brain injury in children. N Engl J Med 2008;358(23):2447-2456
26. Shohami E, Gati I, Beit-Yannai E, et al. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J Neurotrauma 1999;16(5):365-376
27. Glantz L, Avramovich A, Trembovler V, et al. Ischemic preconditioning increases antioxidants in the brain and peripheral organs after cerebral ischemia. Exp Neurol 2005;192(1):117-124
28. Chen G, Shi J, Ding Y, et al. Progesterone prevents traumatic brain injury-induced intestinal nuclear factor kappa B activation and proinflammatory cytokines expression in male rats. Mediators Inflamm 2007;93431
29. Chen G, Shi JX, Qi M, et al. Effects of progesterone on intestinal inflammatory response, mucosa structure alterations, and apoptosis following traumatic brain injury in male rats. J Surg Res 2008;147(1):92-98
30. Hang CH, Shi JX, Li JS, et al. Expressions of intestinal NF-kappaB, TNF-alpha, and IL-6 following traumatic brain injury in rats. J Surg Res 2005;123(2):188-193
31. Hang CH, Shi JX, Sun BW, Li JS. Apoptosis and functional changes of dipeptide transporter (PepT1) in the rat small intestine after traumatic brain injury. J Surg Res 2007;137(1):53-60
32. Zhou ML, Zhu L, Wang J, et al. The inflammation in the gut after experimental subarachnoid hemorrhage. J Surg Res 2007;137(1):103-108
33. Vilalta A, Sahuquillo J, Rosell A, et al. Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases. Intensive Care Med 2008;34(8):1384-1392
34. Utagawa A, Truettner JS, Dietrich WD, Bramlett HM. Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp Neurol 2008;211(1):283-291
35. Margulies S, Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma 2009;26(6):925-939
36. Mautes AE, Thome D, Steudel WI, et al. Changes in regional energy metabolism after closed head injury in the rat. J Mol Neurosci 2001;16(1):33-39
37. Kasturi BS, Stein DG. Progesterone decreases cortical and sub-cortical edema in young and aged ovariectomized rats with brain injury. Restor Neurol Neurosci 2009;27(4):265-275
38. Stein DG, Hurn PD. Effects of sex steroids on damaged neural systems. In: Pfaff DW, Arnold AP, Etgen AM, et al., editors, Hormones, brain and behavior. 2nd edition. Elsevier, Oxford; 2009. p. 2223-2258
39. Sayeed I, Stein DG. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. In: Verhaagen J, Hol EM, Huitinga I, et al., editors, Neurotherapy. Elsevier, New York; 2009. p. i219-37
40. Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 2007;116:77-107
41. Fee DB, Swartz KR, Joy KM, et al. Effects of progesterone on experimental spinal cord injury. Brain Res 2007;1137:146-152
42. Toung TJ, Chen TY, Littleton-Kearney MT, et al. Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab 2004;24(10):1160-1166
43. Cutler SM, Pettus EH, Hoffman SW, Stein DG. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp Neurol 2005;195(2):423-429
44. Gilmer LK, Roberts KN, Scheff SW. Efficacy of progesterone following a moderate unilateral cortical contusion injury. J Neurotrauma 2008;25(6):593-602
45. Baulieu EE, Robel P, Schumacher M. Neurosteroids: beginning of the story. Int Rev Neurobiol 2001;46:1-32
46. Baulieu EE, Robel P. Neurosteroids: a new brain function? J Steroid Biochem Mol Biol 1990;37(3):395-403
47. Schumacher M, Robel P, Baulieu EE. Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci 1996;18(1-2):6-21
48. Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil 2003;6(1):13-22
49. Wright DW, Kellermann AL, Hertzberg VS, et al. ProTECT: A randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007;49(4):391-402
50. Xiao G, Wei J, Yan W, et al. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008;12(2):R61
51. Doppenberg EM, Choi SC, Bullock R. Clinical trials in traumatic brain injury: lessons for the future. J Neurosurg Anesthesiol 2004;16(1):87-94
52. Meffre D, Delespierre B, Gouezou M, et al. The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury. J Neurochem 2005;93(5):1314-1326
53. Coughlan T, Gibson C, Murphy S. Modulatory effects of progesterone on inducible nitric oxide synthase expression in vivo and in vitro. J Neurochem 2005;93(4):932-942
54. Reddy DS, O'Malley BW, Rogawski MA. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 2005;48(1):14-24
55. Sakamoto H, Shikimi H, Ukena K, Tsutsui K. Neonatal expression of progesterone receptor isoforms in the cerebellar Purkinje cell in rats. Neurosci Lett 2003;343(3):163-166
56. Inoue T, Akahira J, Suzuki T, et al. Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab 2002;87(11):5325-5331
57. Guerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull 2002;59(2):105-109
58. Quadros PS, Pfau JL, Wagner CK. Distribution of progesterone receptor immunoreactivity in the fetal and neonatal rat forebrain. J Comp Neurol 2007;504(1):42-56
59. Quadros PS, Lopez V, De Vries GJ, et al. Progesterone receptors and the sexual differentiation of the medial preoptic nucleus. J Neurobiol 2002;51(1):24-32
60. Ozawa H. Steroid Hormones, their receptors and neuroendocrine system. J Nippon Med Sch 2005;72(6):316-325
61. Ghoumari AM, Baulieu EE, Schumacher M. Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 2005;135(1):47-58
62. Pierson RC, Lyons AM, Greenfield LJ. Gonadal steroids regulate GABAA receptor subunit mRNA expression in NT2-N neurons. Brain Res Mol Brain Res 2005;138(2):105-115
63. Lonstein JS, Blaustein JD. Immunocytochemical investigation of nuclear progestin receptor expression within dopaminergic neurones of the female rat brain. J Neuroendocrinol 2004;16(6):534-543
64. Blaustein JD. Progestin receptors: neuronal integrators of hormonal and environmental stimulation. Ann NY Acad Sci 2003;1007:238-250
65. Gruber CJ, Huber JC. Differential effects of progestins on the brain. Maturitas 2003;46(Suppl 1):S71-5
66. Labombarda F, Gonzalez SL, Deniselle MC, et al. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J Neurochem 2003;87(4):902-913
67. Mani SK. Signaling mechanisms in progesterone-neurotransmitter interactions. Neuroscience 2006;138(3):773-781
68. Dufourny L, Skinner DC. Colocalization of progesterone receptors and thyroid hormone receptors alpha in the ovine diencephalon: no effect of estradiol. Neuroendocrinology 2003;77(1):51-58
69. Auger CJ, De Vries GJ. Progestin receptor immunoreactivity within steroid-responsive vasopressin-immunoreactive cells in the male and female rat brain. J Neuroendocrinol 2002;14(7):561-567
70. Attella MJ, Nattinville A, Stein DG. Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav Neural Biol 1987;48(3):352-367
71. Brinton RD, Thompson RF, Foy MR, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol 2008;29(2):313-339
72. Gibson CL, Gray LJ, Bath PM, Murphy SP. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008;131(Pt 2):318-328
73. Vandromme M, Melton SM, Kerby JD. Progesterone in traumatic brain injury: time to move on to phase III trials. Crit Care 2008;12:153
74. Stein DG. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 2008;57(2):386-397
75. Zygun DA, Kortbeek JB, Fick GH, et al. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med 2005;33(3):654-660
76. Cai W, Zhu Y, Furuya K, et al. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 2008;55(2):127-138
77. Behera MA, Dai Q, Garde R, et al. Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF\10A benign breast epithelial cells. Am J Physiol Endocrinol Metab 2009. [Epub ahead of print]
78. Hu Z, Li Y, Fang M, et al. Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegeneration. Curr Med Chem 2009;16(11):1418-1425
79. Sayeed I, Wali B, Stein DG. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 2007;25(2):151-159
80. Mani SK, Portillo W, Reyna A. Steroid hormone action in the brain: cross-talk between signalling pathways. J Neuroendocrinol 2009;21(4):243-247
81. Sayeed I, Parvez S, Winkler-Stuck K, et al. Patch clamp reveals powerful blockade of the mitochondrial permeability transition pore by the D2-receptor agonist pramipexole. FASEB J 2006;20(3):556-558
82. Ziegler E, Bodusch M, Song Y, et al. Interaction of androsterone and progesterone with inhibitory ligand-gated ion channels: a patch clamp study. Naunyn Schmiedebergs Arch Pharmacol 2009;380(4):277-291
83. Djebaili M, Guo Q, Pettus EH, et al. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 2005;22(1):106-118
84. Yao XL, Liu J, Lee E, et al. Progesterone differentially regulates pro-and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury in rats. J Neurotrauma 2005;22(6):656-668
85. Wise PM. Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 2006;138(3):831-835
86. You JM, Yun SJ, Nam KN, et al. Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can J Physiol Pharmacol 2009;87(6):440-447
87. Robertson CL, Puskar A, Hoffman GE, et al. Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp Neurol 2006;197(1):235-243
88. Roglio I, Bianchi R, Gotti S, et al. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 2008;155(3):673-685
89. Garay L, Gonzalez Deniselle MC, Gierman L, et al. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 2008;15(1):76-83
90. De Nicola AF, Labombarda F, Deniselle MC, et al. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front Neuroendocrinol 2009;30(2):173-187
91. Henderson LP. Steroid modulation of GABAA receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology 2007;52(7):1439-1453
92. Pan DS, Liu WG, Yang XF, Cao F. Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed Environ Sci 2007;20(5):432-438
93. Chen G, Shi J, Jin W, et al. Progesterone administration modulates TLRs/NF-kappaB signaling pathway in rat brain after cortical contusion. Ann Clin Lab Sci 2008;38(1):65-74
94. Chen J, Chopp M, Li Y. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci 1999;171(1):24-30
95. Rhodes ME, Frye CA. Actions at GABA (A) receptors in the hippocampus may mediate some antiseizure effects of progestins. Epilepsy Behav 2005;6(3):320-327
96. Moorthy K, Sharma D, Basir SF, Baquer NZ. Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Exp Gerontol 2005;40(4):295-302
97. Chataigneau T, Zerr M, Chataigneau M, et al. Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats. Menopause 2004;11(3):255-263
98. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004;286(2):R233-49
99. Cutler SM, Cekic M, Miller DM, et al. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 2007;24(9):1475-1486
100. Guo Q, Sayeed I, Baronne LM, et al. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol 2006;198(2):469-478
101. Vanlandingham JW, Cutler SM, Virmani S, et al. The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury. Neuropharmacology 2006;51:1078-1085
102. Charalampopoulos I, Remboutsika E, Margioris AN, Gravanis A. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab 2008;19(8):300-307
103. Reddy DS, Apanites LA. Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice. Brain Res 2005;1033(1):96-101
104. Zheng P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol 2009;89(2):134-152
105. Akk G, Covey DF, Evers AS, et al. Mechanisms of neurosteroid interactions with GABA(A) receptors. Pharmacol Ther 2007;116(1):35-57
106. Covey DF. ent-Steroids: novel tools for studies of signaling pathways. Steroids 2009;74(7):577-585
107. Jones LA, Anthony JP, Henriquez FL, et al. Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 2008;125(1):59-69
108. Hwang JY, Duncan RS, Madry C, et al. Progesterone potentiates calcium release through IP3 receptors by an Akt-mediated mechanism in hippocampal neurons. Cell Calcium 2009;45(3):233-242
109. Viero C, Dayanithi G. Neurosteroids are excitatory in supraoptic neurons but inhibitory in the peripheral nervous system: it is all about oxytocin and progesterone receptors. Prog Brain Res 2008;170:177-192
110. Sakamoto H, Ukena K, Kawata M, Tsutsui K. Expression, localization and possible actions of 25-Dx, a membrane associated putative progesterone-binding protein, in the developing Purkinje cell of the cerebellum: a new insight into the biosynthesis, metabolism and multiple actions of progesterone as a neurosteroid. Cerebellum 2008;7(1):18-25
111. Guennoun R, Meffre D, Labombarda F, et al. The membrane-associated progesterone-binding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. Brain Res Rev 2008;57(2):493-505
112. Cekic M, Sayeed I, Stein DG. Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrinol 2009;30(2):158-172